HIKALNSEHikal Limited· PharmaceuticalsMinimalNeutral
Announced Thu, 12 Feb · 11:05 IST

Hikal Limited has informed the Exchange about Copy of Newspaper Publication

HIKAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Hikal Limited has informed BSE and NSE that it published its Q3 FY26 (quarter and nine months ended December 31, 2025) financial results in Business Standard (English) and Mumbai Lakshadeep (Marathi) newspapers on February 12, 2026. This is a routine regulatory compliance filing under Regulation 30 read with Regulation 47 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The detailed Q3 FY26 numbers for Hikal are not included in this specific filing — the newspaper extract shown pertains to other companies. The full results are available on the company's website (www.hikal.com) and on the BSE/NSE websites.

Likely market impact

This is a procedural compliance filing with no new business or financial information beyond confirming that Q3 FY26 results have been publicly disseminated as required. No material impact on shareholders or stock price is expected from this disclosure alone; investors should refer to the actual Q3 results filed with the exchanges for fundamental analysis.